2 Small-Cap Stocks to Keep an Eye On and 1 That Underwhelm
If you want accessible, useful, and downright cheap funds to anchor your portfolio, these three index funds can do it better than most.
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
Berkshire Hathaway has just released its 13F filing for the third quarter of 2025.
DENVER , Nov. 14, 2025 /PRNewswire/ -- DaVita Inc. Â (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat at the Wolfe Research Healthcare...
Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
DaVita has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
DaVita’s Q3 Earnings Call: Our Top 5 Analyst Questions
1 Value Stock with Impressive Fundamentals and 2 That Underwhelm